PEBO Q1 2026 Earnings EPS Slightly Misses Consensus as Shares Rise 116 NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase GPMT Q1 2026 Earnings NarrowerThanExpected Loss Signals Potential Stabilization COUR Q1 2026 Earnings EPS Falls Short of Estimates Amid Mixed Demand Signals LADR Q1 2026 Earnings EPS Misses Estimates Stock Rises 15 ALRM Q1 2026 Earnings EPS Beats Estimates by 54 Stock Edges Higher